Medicaid generics save low-income patients up to 90% on prescription costs, with average copays of just $6.16 compared to $56 for brand-name drugs. Learn how rebates, formularies, and policy changes keep medications affordable.
Generic drugs save billions but many patients still distrust them. Research shows clear, simple conversations with healthcare providers are the most effective way to build confidence-and improve adherence.
Generic medications cost far less than brand-name drugs because they don't require expensive clinical trials or marketing. They're just as safe and effective, saving patients and insurers billions each year.
India and China dominate the global generic drug market, but their roles are very different. India leads in volume and speed; China controls the raw ingredients. Emerging economies like Vietnam and Cambodia are carving out vital niches. Here’s how it all works-and why dual-sourcing is now essential.
False advertising in generic drugs misleads patients into avoiding affordable medications. Learn the legal risks, FDA rules, and how deceptive ads harm health - and what you can do about it.
Learn the key differences between biosimilars and generics to make informed treatment choices. Understand safety, cost, and when each option is right for you.
Learn how to safely compare generic drug manufacturers and understand why pill appearance changes. Discover how bioequivalence ensures safety, how to identify your pills, and when to stick with the same manufacturer.
NTI generics require specialized bridging studies to ensure safety, with tighter bioequivalence limits and complex study designs. Learn why these drugs demand more rigorous testing than standard generics and how regulators are balancing access with patient safety.
Clinicians are raising alarms about the quality of generic drugs made overseas, citing higher rates of adverse events and unreliable manufacturing. Here’s what’s really happening behind the pill label.